Management of diabetic patients by general practitioners in France 1997: An epidemiological study

Diabetes and Metabolism

Volumn 26, Issue 1, 2000, Pages 43-49

  Le Floch, J P ^a   Thervet, F ^b   Desriac, I ^c   Boyer, J F ^c   Simon, D ^d  

^a Clinique de Villecresnes   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Complications; Diabetes; Epidemiology; Health care; Risk factors; Self monitoring; Treatment

Indexed keywords

INSULIN;

ADULT; ARTICLE; DISEASE DURATION; FEMALE; FRANCE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR;

ALCOHOL DRINKING; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; FRANCE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 0034059287     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Delcourt C, Papoz L. Les différents types de diabète en France métropolitaine. In Le diabète et ses complications dans la population française. Les éditions INSERM 1996, 13-33.
2. Chwalow J, Costagliola D, Mesbah M, Eschwège E. Prise en charge du diabète de type 2 en France: attitudes et habitudes dans un échantillon représentatif de médecins généralistes. Diabetes Metab, 1995, 20, 458-464.
3. Delcourt C, Vauzelle-Kervroëdan F, Cathelineau G, Papoz L et al. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. J Diab Comp. 1998, 12, 88-95.
4. Eschwège E, Simon D, Balkau B. Le diabète de type 2 vu par l'épidémiologiste. Dis Manage Health Outcome, 1998, 4 (suppl). 1-12.
5. Haut Comité de la Santé Publique. Rapport du groupe de travail "Diabète, Prévention, Dispositifs de Soins et Education du Patient". Ministère de l'Emploi et de la Solidarité. Paris mai 1998.
6. Vauzelle-Kervoëdan F, Forhan A, Javoy F, Fender P, Eschwège E. Pharmacoépidémiologie du diabète: apports d'une enquéte des caisses d'assurance maladie. Diabetes Metab, 1999, 25, 163-171.
7. The DECODE Study Group (European Diabetes Epidemiology Study Group). Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet, 1999, 354, 617-621.
8. European Diabetes Epidemiology Group. Epidemiological considerations related to the new diagnostic criteria for diabetes mellitus. Diabetologia, 1998, 41, 51-52.
9. Balkau B, Eschwège E, Tichet J, Marre M and the DESIR Study Group. Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study - DESIR. Diabetes Metab, 1997, 23, 428-434.
10. American Diabetes Association Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1998, 21 (suppl 1), S5-S19.
11. European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of european epidemiological data. BMJ, 1998, 317, 371-375.
12. ANAES. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications. Diabetes Metab, 1999, 25 (suppl 2), 9-13.
13. Balkau B, Shipley M, Jarret RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwège E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care, 1998, 21, 360-367.
14. Wroblewski M, Gottsater A, Lindgarde F, Fernlund P, Sundkvist G. Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care, 1998, 21, 250-255.
15. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric acid calculus disease. Am J Clin Nutr, 1956, 4, 20-34.
16. ADA. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care, 1998. 21 (suppl 1), S32-S35.
17. ADA. Diabetes mellitus and exercise. Diabetes Care, 1998, 21(suppl 1), S40-S44.
18. Gillery P, Dumont G, Vassault A. Evaluation of GHb assays in France by national quality control surveys. Diabetes Care, 1998, 21, 265-270.
19. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependant diabetes mellitus. N Engl J Med, 1995, 332, 1251-1255.
20. ADA. Implications of the diabetes control and complications trial. Diabetes Care, 1998, 21 (suppl 1), S88-S90.
21. Southwell A, Eckland D. Managing the burden of type 2 diabetes: an international survey of physicians. Pract Diab Intern, 1997, 14, 201-206.
22. Faas A, Schellevis FG, van Eijk JTM. The efficacity of self-monitoring of blood glucose in NIDDM subjects. Diabetes Care, 1998, 20, 1482-1486.
23. ADA. Tests of glycemia in diabetes. Diabetes Care, 1998, 21 (suppl 1), S68-S71.
24. Harris MI, Modan M. Screening for NIDDM. Why is there no national program? Diabetes Care, 1994, 17, 440-444.
25. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 1998, 317, 703-713.